RenovoRx Inc
RNXT
Get informed when a big investor buys or sells
+ FollowMarket Cap$57.67M
Close$
$0.35
69.1% downside
Current Fair Value
69.1% downsideOvervalued by 69.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $57.67 Million |
|---|---|
| Enterprise Value | $48.45 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.32 |
| Beta | 0.97 |
| Outstanding Shares | 47,298,148 |
Return
| Return on Equity | -136.82% |
|---|---|
| Return on Assets | -107.09% |
| Return on Invested Capital | -136.65% |
Valuation & Multiples
| P/E Ratio | -4.05 |
|---|---|
| PEG | -732.22 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 24.52 |
| Enterprise Value to EBIT | -3.7 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.03 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 13, 2026
EPS Estimate
$-0.08
Average shareholder expectationRevenue Estimate
$703,750
Average shareholder expectationNext Earnings Call
Expected Date
November 12, 2026
EPS Estimate
$-0.05
Average shareholder expectationRevenue Estimate
$1.06 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 19.45%▼ 3.07% |
|---|---|
| Total Invested | $9.00M▲ 4.90% |
| Investors Holding | 29▼ 2.00% |
ESG Score
No data
About RenovoRx Inc
2,021 employees